重症监护病房念珠菌血症患者的临床特征与死亡预测因素
该研究回顾性分析北京大学人民医院ICU 2010年1月至2017年12月收治的95例念珠菌血症患者,收集临床资料并分析感染特征与预后。按院内生存状态分为死亡组和生存组,比较两组指标差异,采用多因素Logistic回归分析死亡独立危险因素。结果显示院内病死率57.9%,白色念珠菌占比最高(58.9%),死亡组APACHE II、SOFA评分更高,抗真菌治疗不足和感染源控制不足比例更高。多因素分析证实APACHE II、SOFA、抗真菌治疗不足和感染源控制不足是死亡的独立危险因素。
要点
- ICU念珠菌血症患者院内病死率达57.9%(55/95),病情重、预后差。
- 死亡组APACHE II评分26.6±2.2 vs 生存组22.1±3.6,SOFA评分7.9±2.0 vs 4.7±2.4,均显著更高(P<0.01)。
- 抗真菌治疗不足(OR=12.084,P=0.006)和感染源控制不足(OR=7.332,P=0.024)是死亡的独立危险因素。
- 死亡组抗真菌治疗不足率49.1% vs 生存组10.0%,感染源控制不足率60.0% vs 12.5%(均P<0.01)。
- 腹腔感染是主要感染部位,死亡组占比49.1% vs 生存组35.0%(P<0.05)。
适用人群与场景
- 2010年1月至2017年12月北京大学人民医院ICU收治的念珠菌血症患者,共95例,男性55例,平均年龄69.3±16.5岁。
研究设计与关键结果
- 研究类型为回顾性分析,纳入95例ICU念珠菌血症患者,男性55例,平均年龄69.3±16.5岁,APACHE II评分24.7±3.6,SOFA评分6.6±2.7。
- 白色念珠菌占58.9%(56例),为最常见病原体。
- 32例(33.7%)抗真菌治疗不足,38例(40.0%)感染源控制不足,55例(57.9%)院内死亡。
- 死亡组较生存组年龄更大(72.5±14.6岁 vs 64.9±18.0岁,P<0.05),APACHE II评分更高(26.6±2.2 vs 22.1±3.6,P<0.01),SOFA评分更高(7.9±2.0 vs 4.7±2.4,P<0.01),糖皮质激素治疗率更高(18.2% vs 10.0%,P<0.05),白色念珠菌比例更高(69.1% vs 45.0%,P<0.05),光滑念珠菌比例更高(10.9% vs 7.5%,P<0.05),多部位念珠菌感染率更高(47.3% vs 17.5%,P<0.05),腹腔感染更常见(49.1% vs 35.0%,P<0.05),脓毒症发生率更高(87.3% vs 62.5%,P<0.01),抗真菌治疗不足率更高(49.1% vs 10.0%,P<0.01),感染源控制不足率更高(60.0% vs 12.5%,P<0.01)。
- 多因素Logistic回归分析显示,APACHE II(OR=1.605,P=0.002)、SOFA(OR=1.501,P=0.029)、抗真菌治疗不足(OR=12.084,P=0.006)和感染源控制不足(OR=7.332,P=0.024)是ICU念珠菌血症患者死亡的独立危险因素。
证据类型、等级与局限
- 证据类型:回顾性分析(单中心)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为APACHE II、SOFA、抗真菌治疗不足和感染源控制不足是死亡的独立危险因素,提示应关注这些因素以改善预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the clinical characteristics and predictors of mortality in patients with candidemia in intensive care unit (ICU).
METHODS: The patients with candidemia admitted to ICU of Peking University People's Hospital from January 2010 to December 2017 were enrolled. The general clinical data, indicators related to Candidia infection and prognosis were collected, and the clinical characteristics, infection characteristics and prognosis of patients with candidiasis were analyzed. Patients were divided into death group and survival group according to hospital survival status. The differences of each index were compared between two groups. The independent risk factors of mortality in patients with candidemia were analyzed by multivariate Logistic regression analysis.
RESULTS: A total of 95 patients (55 males) with candidemia were included, with an average age of (69.3±16.5) years, acute physiology and chronic health evaluation II (APACHE II) was 24.7±3.6, sequential organ failure assessment (SOFA) was 6.6±2.7. Candida albicans accounted for the largest proportion of Candida infections (n = 56, 58.9%). Thirty-two (33.7%) patients received inadequate antifungal therapy and 38 (40.0%) patients received inadequate source control. Fifty-five (57.9%) patients were died in hospital. Compared with the survival group, patients in the death group was older (years: 72.5±14.6 vs. 64.9±18.0, P < 0.05), had higher APACHE II and SOFA scores (26.6±2.2 vs. 22.1±3.6, 7.9±2.0 vs. 4.7±2.4, both P < 0.01), higher rate of glucocorticoid treatment (18.2% vs. 10.0%, P < 0.05), and higher proportion of Candida albicans and Candida glabrata (69.1% vs. 45.0%, 10.9% vs. 7.5%, both P < 0.05), the rate of multi-site Candida infection also significantly increased (47.3% vs. 17.5%, P < 0.05). Intra-abdominal infection was the primary infection site and more common in death group (49.1% vs. 35.0%, P < 0.05). The rates of sepsis (87.3% vs. 62.5%), inadequate antifungal therapy (49.1% vs. 10.0%), inadequate source control (60.0% vs. 12.5%) in death group were all higher than those in survival group (all P < 0.01). It was shown by multivariate Logistic regression analysis that APACHE II [odds ratio (OR) = 1.605, P = 0.002, β = 0.473], SOFA (OR = 1.501, P = 0.029, β = 0.406), inadequate antifungal therapy (OR = 12.084, P = 0.006, β = 2.492) and inadequate source control (OR = 7.332, P = 0.024, β = 1.992) were independent risk factors for mortality in ICU patients with candidemia.
CONCLUSIONS: Candidemia patients were severe and had poor prognosis. APACHE II, SOFA, inadequate antifungal therapy and inadequate source control were independent risk factors of mortality.
参考来源
- Zhao H, Wang Q, Wu P, et al. [Clinical characteristics and predictors of mortality in patients with candidemia in intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30439310. doi:10.3760/cma.j.issn.2095-4352.2018.010.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。